Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Safety and tolerability of brimonidine purite 0.1% and brimonidine purite 0.15%: a meta-analysis of two phase 3 studies
Current Medical Research and Opinion, 06/24/09
Cantor LB et al. - Brimonidine P 0.1% has improved systemic safety and tolerability compared with brimonidine P 0.15%. The ocular safety and tolerability of the formulations are similar. The present meta-analysis is based on only two clinical studies, and additional studies further evaluating the safety and tolerability of these medications are warranted.
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
Allos Therapeutics' FOLOTYN Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Lymphoma
Allos Therapeutics, 12/09/09
First-in-Human Study Demonstrating Pharmacological Activation of Heme Oxygenase-1 in Humans
Clinical Pharmacology & Therapeutics, 12/08/09
Amgen Presents Data From First Nplate Study in Children With Chronic ITP
Amgen, 12/08/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Developments in factor Xa inhibitors for the treatment of thromboembolic disorders
Medicinal Research Reviews, 12/09/09
Monitored anesthesia care (MAC) sedation: clinical utility of fospropofol
Therapeutics and Clinical Risk Management, 12/09/09
Pharmacotherapy of diabetic foot osteomyelitis
Expert Opinion in Pharmacotherapy, 12/09/09
Sponsor
Article Search
Sponsor


See Latest Articles


